mRNA Solution

mRNA technology has changed the thinking of treatment, including vaccines. With its advantages in clinical manifestations and production, the treatment based on mRNA technology will give birth to new treatment fields and treatment schemes. However, mRNA-LNP therapy drugs need high delivery efficiency and accurate delivery location, and there are still many challenges in process distance and supervision. How to apply the concepts of QbD and Risk Assessment to process development and production is the core of one-stop plan. Tofflon can provide solutions for mRNA technology and LNP technology from laboratory to mass production, which has successfully helped mRNA enterprises to break through the core production process and go public, and can provide key support from research and development to the implementation of production strategies.

Tofflon Science and Technology Group Co., Ltd.

Purification Process
Cryopreservation Of The Original Solution
Auxiliary System
Preparation
Isolation System
Isolation System1
Isolation System2

Centrifugal

Membrane Filtration

Chromatographic Process

Parts

(M+E+C)&AI&

Relying on the understanding of regulations and processes, provide reliable end-to-end equipment and facilities from R&D to commercialization; Through planning and design, procurement management, engineering construction, system verification and other processes, integrated delivery of factories with specific functions; Provide core process consumables such as culture medium, filler, filter and disposable reaction bag to assist process optimization and solve the problem of stock solution production; Relying on information and intelligent time experience, we will provide forward-looking and professional digital planning to help enterprises transform digitally.